The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Julia Lai‐Kwon; Christine Khoo; Serigne Lo; Donna Milne; Mustafa Abdi Mohamed; Jeanette Raleigh; Kortnye Smith; Karolina Lisy; Shahneen Sandhu; Michael Jefford

doi:10.1093/annonc/mdy439

Back

The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Article 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors

Julia Lai‐Kwon, Chloe Khoo, Serigne Lo, Donna Milne, Mustafa Abdi Mohamed, Jeanette Raleigh, Kortnye Smith, Karolina Lisy, Shahneen Sandhu, Michael Jefford

Article2018

Survivorship experience for patients (pts) with metastatic melanoma (MM) on long-term targeted therapy (TT).

Chloe Khoo, Julia Elizabeth Lai-Kwon, Serigne Lo, Donna Milne, Mustafa Abdi Mohamed, Jeanette Raleigh, Kortnye Smith, Michael Jefford, Shahneen Sandhu

Article2018

Survivorship experience for patients (pts) with metastatic melanoma (MM) on immunotherapy (IT).

Julia Elizabeth Lai-Kwon, Chloe Khoo, Serigne Lo, Donna Milne, Mustafa Abdi Mohamed, Jeanette Raleigh, Kortnye Smith, Shahneen Sandhu, Michael Jefford

Article2017

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Preprint2023

Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S. Wilmott, Richard A Scolyer, Georgina V. Long